TET2 and angioimmunoblastic T-cell lymphoma: In this review, we focus on exploring the current role of TET2 mutations in the pathogenesis of AITL and how mutations in TET2 as well as other genes (RHOA, DNMT3A, and IDH2) cooperatively contribute to disease pathogenesis.